Page last updated: 2024-10-27

gabapentin and Bronchopulmonary Dysplasia

gabapentin has been researched along with Bronchopulmonary Dysplasia in 1 studies

Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.

Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdi, HH1
Maitre, NL1
Benninger, KL1
Hester, ME1
Slaughter, JL1

Other Studies

1 other study available for gabapentin and Bronchopulmonary Dysplasia

ArticleYear
Gabapentin Use for Hospitalized Neonates.
    Pediatric neurology, 2019, Volume: 97

    Topics: Analgesics, Non-Narcotic; Anticonvulsants; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Chromoso

2019